| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/12/2008 | WO2008109742A1 Modulation of complement system activation for treatment of bleeding-related inflammation |
| 09/12/2008 | WO2008109737A1 Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators |
| 09/12/2008 | WO2008109727A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 09/12/2008 | WO2008109407A2 Extracellular matrix-derived gels and related methods |
| 09/12/2008 | WO2008109385A2 Oral administration of a calcitonin |
| 09/12/2008 | WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety |
| 09/12/2008 | WO2008109178A1 Metalloprotease inhibitors containing a squaramide moiety |
| 09/12/2008 | WO2008109119A2 Wnt compositions and methods of use thereof |
| 09/12/2008 | WO2008108395A1 Process for producing osteocalcin-containing extract |
| 09/12/2008 | WO2008108284A1 Rankl production inhibitor |
| 09/12/2008 | WO2008107508A1 Use of snail1 activity inhibiting compounds in the preparation of pharmaceutical compositions intended for the treatment of chondrodystrophies, method for identifying inhibiting compounds, pharmaceutical compositions, chondrodystrophy diagnosis method and applications thereof |
| 09/12/2008 | WO2008089933A3 Benzoquinazole derivatives |
| 09/12/2008 | WO2008071650A3 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 09/12/2008 | WO2008051568A9 Methods and compositions for treatment of bone defects with placental cell populations |
| 09/12/2008 | CA2680312A1 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/12/2008 | CA2680212A1 Substituted phenoxy aminothiazolones as estrogen related receptor-.alpha. modulators |
| 09/12/2008 | CA2679944A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators |
| 09/12/2008 | CA2679924A1 Milk-derived basic protein fraction for inhibiting rankl production |
| 09/12/2008 | CA2675463A1 Association of compounds inhibiting melanogenesis and use thereof in cosmetics and dermatology |
| 09/12/2008 | CA2621332A1 Pharmaceutical compositions comprising calcium dobesilate for the treatment of tendinitis |
| 09/11/2008 | US20080221205 effect on bone proliferation with the side effect reduced; degenerative bone disease and rheumatoid arthritis |
| 09/11/2008 | US20080221196 Pharmaceutically active isoindoline derivatives |
| 09/11/2008 | US20080221195 N [(R)-1-Hydroxymethyl-2-(1H-indol-3-yl)-ethyl]-5-phenylethynyl-2-propoxy-benzamide; fertility control in men or in women, or for the prevention and/or treatment of osteoporosis; FSH antagonists |
| 09/11/2008 | US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds |
| 09/11/2008 | US20080221179 SUBSTITUTED PHENOXY AMINOTHIAZOLONES as estrogen related receptor-alpha modulators |
| 09/11/2008 | US20080221172 Use of Quaternary Pyridinium Compounds for Vasoprotection and/or Hepatoprotection |
| 09/11/2008 | US20080221170 Chronic pain, allodynia, hyperalgesia, fatigue, sleep disturbance, and depression; Central Sensitivity Syndrome; kits |
| 09/11/2008 | US20080221139 Novel Compounds |
| 09/11/2008 | US20080221128 Metalloprotease inhibitors containing a squaramide moiety |
| 09/11/2008 | US20080221125 Novel heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 09/11/2008 | US20080221123 geranylgeranyltransferase I inhibitors; treatment of neoplasia, hyperproliferative cell growth, psoriasis, intimal hyperplasia (restinosis) and chronic inflammatory diseases including rheumatoid and osteoarthritis |
| 09/11/2008 | US20080221095 increased potency and selectivity in relation to currently known MMP-13, MMP-8 and MMP-3 inhibitors; treating rheumatoid arthritis, osteoarthritis or inflammation; squaramide or benzoxazinone moiety |
| 09/11/2008 | US20080221094 Metalloprotease inhibitors containing a squaramide moiety |
| 09/11/2008 | US20080221093 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/11/2008 | US20080221092 Heterobicyclic metalloprotease inhibitors |
| 09/11/2008 | US20080221091 Metalloprotease inhibitors containing a heterocyclic moiety |
| 09/11/2008 | US20080221083 Heterobicyclic metalloprotease inhibitors |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221071 Comprises lumisterol and tachysterol, for topical administration |
| 09/11/2008 | US20080221070 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 09/11/2008 | US20080221062 Non-steroidal anti-inflammatory drugs bound to hyaluronic acid through a covalent bond via a spacer having a biodegradable region and disease-modifying anti-rheumatic drugs; salicylic acid, aspirin, mefenamic acid, tolfenamic acid; arthritis, suppress inflammation and pain; parenteral, topical |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221023 Administering protein hydrolysates; dipeptidyl peptidase IV diseases; obesity, type II diabetes mellitus, autoimmune diseases |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220099 Nutritional composition |
| 09/11/2008 | US20080220086 Injectable Composite Material Suitable for Use as a Bone Substitute |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080220075 Nanoparticulate compositions comprising at least one poorly soluble angiogenesis inhibitor and at least one surface stabilizer are described. The nanoparticulate compositions have an average particle size of less than about 2000 nm. The invention also describes methods making and using such compositions. |
| 09/11/2008 | US20080220057 Therapeutic compounds and methods of use |
| 09/11/2008 | US20080220044 Cancellous construct with support ring for repair of osteochondral defects |
| 09/11/2008 | US20080219962 Method to Enhance the Bone Formation Activity of Bmp by Runx2 Acetylation |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/11/2008 | DE102007012276A1 Zusammensetzung zur Behandlung von Knochen- und/oder Knorpeldefekten Composition for the treatment of bone and / or cartilage defects |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1966227A1 Crystalline forms of ibandronate sodium |
| 09/10/2008 | EP1966156A2 New compounds iii |
| 09/10/2008 | EP1771181B1 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 09/10/2008 | EP1618875B1 Composition for inhibition or prevention of bone density lowering |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
| 09/10/2008 | CN101259277A Novel orthopaedics medicaments carrier system and preparation thereof |
| 09/10/2008 | CN101259255A Externally-applied medicament for treating wrick |
| 09/10/2008 | CN101259240A Traditional Chinese medicine composition for curing hyperosteogeny and preparation thereof |
| 09/10/2008 | CN101259222A Medicaments for treating bone fracture bone fracture disease |
| 09/10/2008 | CN101259213A Health drug pillow |
| 09/10/2008 | CN101259200A Orally-administered and externally-applied specific medicine for treating bone injury disease, protrusion of lumbar intervertebral discs and wrick |
| 09/10/2008 | CN101259194A Combined medicaments for treating rheumatism |
| 09/10/2008 | CN101259178A Chinese medicine preparation for treating rheumatoid arthritis |
| 09/10/2008 | CN101259176A Blackberry capsule for treating gout and preparation thereof |
| 09/10/2008 | CN101259173A Blood circulation promoting vein relaxing medicine |
| 09/10/2008 | CN101259163A Content detecting method for lamioplomis rotate plaster |
| 09/10/2008 | CN101259142A Bone peptide injection preparation |
| 09/10/2008 | CN101259133A Zoledronic acid for preparing medicaments for preventing and treating osteoporosis |
| 09/10/2008 | CN101258893A Xylitol nicotinamide chewing gum and manufacturing method thereof |
| 09/10/2008 | CN100417659C Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/10/2008 | CN100417415C Soakage of medication for treating arthritis |
| 09/10/2008 | CN100417401C Medicine for blood stanching, stasis transforming and bone joining |
| 09/10/2008 | CN100417394C Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423015 Treatment of p53-positive tumors with benzimidazole derivatives such as fenbendazole or mebendazole |
| 09/09/2008 | US7423007 Cxcr4 antagonist and use thereof |
| 09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 09/09/2008 | US7422740 Capable of inhibiting the cell division cycle in a target cell; for therapy of proliferative cell disorders and intracellular pathogens |
| 09/09/2008 | CA2460865C Quinoline derivatives as neuropeptide y antagonists |
| 09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/09/2008 | CA2287881C Vitamin d3 analogs with bis c-20 side chains |
| 09/04/2008 | WO2008106600A1 Bazedoxifene bis-phosphorates |
| 09/04/2008 | WO2008106478A1 Compositions and methods for modification of target cells and to their uses thereof |
| 09/04/2008 | WO2008105526A1 Macrocyclic compound |
| 09/04/2008 | WO2008105498A1 Pharmaceutical composition for ameliorating inflammation induced by il-17 |
| 09/04/2008 | WO2008105476A1 Circadian rhythm genes and clock motif |